Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage.
Irradiation and DNA-damaging chemotherapeutic agents are commonly used in anticancer treatments. Following DNA damage FOXM1 protein levels are often elevated. In this study, we sought to investigate the potential role of FOXM1 in programmed cell death induced by DNA-damage. Human cancer cells after...
Main Authors: | Marianna Halasi, Andrei L Gartel |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Acceso en liña: | http://europepmc.org/articles/PMC3290538?pdf=render |
Títulos similares
-
Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells.
por: Uppoor G Bhat, et al.
Publicado: (2009-01-01) -
FoxM1 is a general target for proteasome inhibitors.
por: Uppoor G Bhat, et al.
Publicado: (2009-08-01) -
Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells
por: Mikhail S. Chesnokov, et al.
Publicado: (2021-07-01) -
FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML
por: Mikhail S Chesnokov, et al.
Publicado: (2021-07-01) -
Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors
por: Andrei L. Gartel
Publicado: (2014-01-01)